Earlier, I spoke about VAN. And the Nopain Act, both of which will have an impact in 2025. Right now. We are seeing early results that the Crosslink partnership is beginning to drive growth. Our team ...
Heron Therapeutics Inc (NASDAQ:HRTX) reported a significant increase in product gross profit margin to 71% for Q3 2024, up from 42% in the same period in 2023. The Crosslink partnership is showing ...
SAN MARCOS, Texas, Nov. 13, 2024 /PRNewswire/ -- X-Bow Systems Inc (X-Bow), the nation's leading non-traditional producer of advanced solid rocket motors (SRMs) and defense technologies, and Texas ...